Format

Send to

Choose Destination
Br J Haematol. 2019 Apr 2. doi: 10.1111/bjh.15912. [Epub ahead of print]

Venetoclax is an option in B-cell prolymphocytic leukaemia following progression on B-cell receptor pathway inhibitors.

Author information

1
Department of Haematology, Rotherham Foundation Trust, Rotherham, UK.

KEYWORDS:

B-cell prolymphocytic leukaemia; BCL2; venetoclax

PMID:
30941750
DOI:
10.1111/bjh.15912

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center